High level of KLHL5 in STAD is related with a poorer OS and DFS; particularly, it is significantly correlated with prognosis in lymph node–positive patients, which indicates that KLHL5 is a potential biomarker of tumor metastasis. This evidence concerns the gene KLHL5 and gastric adenocarcinoma.